Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, ...

Rural populations face unique challenges in cancer prevention and care. Geographic isolation, economic constraints, and a ...

Genmab A/S (Nasdaq: GMAB) announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy ...

The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) for advanced or recurrent cervical cancer that has progressed on or after ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat advanced or recurrent cervical cancer that progressed on or following ...

Women in Papua New Guinea are being strongly encouraged to undergo early screening for cervical cancer to prevent the ...

Cancer has long been associated with old age; however, in recent years, there has been an alarming rise in cancer diagnoses among younger populations.